Prevalence and immunopathologic characteristics of seropositive and seronegative hepatitis B virus-associated membranous nephropathy: a retrospective study of 420 biopsy-proven cases

Prevalence and immunopathologic characteristics of seropositive and seronegative hepatitis B virus-associated membranous nephropathy: a retrospective study of 420 biopsy-proven cases

Background This retrospective study aims to investigate the prevalence and immunopathologic characteristics of seropositive and seronegative hepatitis B virus-associated membranous nephropathy (HBV-MN).Methods Clinicopathologic and serologic records of 420 patients with histologically confirmed HBV-...

Full description

Saved in:

Bibliographic Details
Main Authors:	Haitao Lu, Qianqian Xu, Guming Zou, Hongmei Gao, Yue Yang, Wenge Li, Li Zhuo
Format:	Article
Language:	English
Published:	Taylor & Francis Group 2024-12-01
Series:	Renal Failure
Subjects:	Hepatitis B virus HBV-associated membranous nephropathy (HBV-MN) seroprevalence membranous nephropathy (MN) anti-phospholipase A2 receptor antibody
Online Access:	https://www.tandfonline.com/doi/10.1080/0886022X.2024.2313180
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Clinicopathological characteristics and outcomes of PLA2R related idiopathic membranous nephropathy in patients with seronegative PLA2R antibodies
by: Xue Li, et al.
Published: (2024-12-01)

Prevalence and prognosis of malignancy in THSD7A-associated membranous nephropathy: a systematic literature review and clinical case study
by: Qianqian Xu, et al.
Published: (2024-12-01)

Fibrinogen-albumin ratio predicts treatment response in phospholipase A2 receptor-associated membranous nephropathy with nephrotic syndrome
by: Suyan Duan, et al.
Published: (2024-12-01)

Exploration of rituximab treatment strategies for membranous nephropathy adapted to the Chinese healthcare environment
by: Xiaolong Wang, et al.
Published: (2025-01-01)

Evidence from mendelian randomization identifies several causal relationships between primary membranous nephropathy and gut microbiota
by: Jianwei Wu, et al.
Published: (2024-12-01)

Clinical study, network pharmacology, and molecular docking of Kunxian capsule in treating idiopathic membranous nephropathy
by: Jia Lv, et al.
Published: (2025-02-01)

Global and national public awareness and interest in glomerular diseases from 2004 to 2024
by: Suryanarayanan Balakrishnan, et al.
Published: (2025-01-01)

Efficacy and safety of Mahuang Fuzi and Shenzhuo Decoction for treatment of primary membranous nephropathy: a multicenter prospective trial
by: Naiqian Zhang, et al.
Published: (2024-12-01)

Coexistence of anti-glomerular basement membrane disease and IgA nephropathy: an illustrative case and comprehensive literature review
by: Zewei Chen, et al.
Published: (2024-12-01)

Hepatitis B virus infections in pregnant women and children in the era of HBV elimination
by: Malgorzata Pawlowska
Published: (2024-12-01)

Toluene Conversion by Using Different Morphology MnO2 Catalyst
by: Huaijian Wang, et al.
Published: (2022-01-01)

Sulphuric acid leaching of low/medium grade managanese ores using a novel nitrogeneous reductant-NH3NH2HSO4
by: Hariprasad D., et al.
Published: (2013-01-01)

Dysregulation in the microbiota by HBV and HCV infection induces an altered cytokine profile in the pathobiome of infection
by: Marcos Daniel Mendes Padilha, et al.
Published: (2025-01-01)

Surveillance Following Hepatitis B Surface Antigen Loss: An Issue Requiring Attention
by: Shuai-Wen Huang, et al.
Published: (2024-12-01)

Oridonin ameliorates renal fibrosis in diabetic nephropathy by inhibiting the Wnt/β-catenin signaling pathway
by: Jushuang Li, et al.
Published: (2024-12-01)

Modelling and Simulation of The Spread of HBV Disease.
by: Niyirora, Ignatius
Published: (2023)

Prevalence of hepatitis B virus and associated factors among blood donors in Hossana blood bank catchment area, Southern Ethiopia
by: Mesfin Menza Jaldo, et al.
Published: (2025-01-01)

Seroprevalence characteristics of hepatitis E virus among blood donors infected with hepatitis B virus
by: YU Qin, et al.
Published: (2025-01-01)

Hepatitis B Virus in Polish Blood Donors in the Period 2005–2019—Significant Changes in Epidemiology and Demographic Characteristics of Infected Donors
by: Aneta Kopacz, et al.
Published: (2025-01-01)

Clinicopathological characteristics and gene mutations in 11 patients with lipoprotein glomerulopathy
by: Yan Qin, et al.
Published: (2024-12-01)

Effect of cubebin against streptozotocin-induced diabetic nephropathy rats via inhibition TNF-α/NF-κB/TGF-β: in vivo and in silico study
by: Rahamat Unissa Syed, et al.
Published: (2025-02-01)

Editorial: Pathogenesis and clinical treatment of diabetic nephropathy
by: Ziyun Xu, et al.
Published: (2025-02-01)

Novel immune cross-talk between inflammatory bowel disease and IgA nephropathy
by: Qianqian Yan, et al.
Published: (2024-12-01)

Comparative evaluation of APRI and MELD scores in the prediction of complications of chronic hepatitis in patients infected with hepatitis B or C viruses in Lubumbashi, democratic republic of Congo
by: Arsène Kabamba-Tshikongo, et al.
Published: (2025-02-01)

Nucleoside analogues in treatment of liver cirrhosis as an outcome of chronic hepatitis B
by: I. G. Bakulin
Published: (2009-02-01)

Prevalence of viral hepatitis B and C infection and associated factors among pregnant women in southeast Ethiopia: community-based crossectional study
by: Nuruzelam Mohammed, et al.
Published: (2025-02-01)

Synthesis of some benzimidazole derivatives endowed with 1,2,3-triazole as potential inhibitors of hepatitis C virus
by: Youssif Bahaa G. M., et al.
Published: (2016-06-01)

The endoplasmic reticulum degradation-enhancing α-mannosidase-like protein 3 attenuates the unfolded protein response and has pro-survival and pro-viral roles in hepatoma cells and hepatocellular carcinoma patients
by: Alina-Veronica Ghionescu, et al.
Published: (2025-01-01)

Asian Perspective on Hepatitis B Virus and Hepatitis C Virus Elimination
by: Apichat Kaewdech, et al.
Published: (2024-12-01)

Anti-HBs Positivity Related to Past HBV Infection and Vaccination in Older Adults in Polish Population—Cohort-Based Study
by: Katarzyna Zięba, et al.
Published: (2024-12-01)

Assessment of Some Heavy Metals and Trace Elements in a Sample of Patients with Viral Hepatitis in Baghdad
by: Najlaa Fattah-Allah Rasheed, et al.
Published: (2022-09-01)

Identification and validation of glycolysis-related diagnostic signatures in diabetic nephropathy: a study based on integrative machine learning and single-cell sequence
by: Xiaoyin Wu, et al.
Published: (2025-01-01)

High triglyceride-glucose index in patients with diabetes mellitus is associated with an increased likelihood of nephropathy development: evidence from a meta-analysis among Asian population
by: Raphael Enrique Tiongco, et al.
Published: (2025-01-01)

Efek Kedelai Terhadap Faal Ginjal Diabetes Melitus
by: Putri Dafriani
Published: (2011-12-01)

α-methyltryptophan-mediated protection against diabetic nephropathy in db/db mice as studied with a metabolomics approach
by: Aimin Cai, et al.
Published: (2025-01-01)

Characteristics, pathogenic and therapeutic role of gut microbiota in immunoglobulin A nephropathy
by: Kaijin Yao, et al.
Published: (2025-02-01)

Immunosuppressive treatment results in patients with primary IgA nephropathy in Turkiye; the data from TSN-GOLD working group
by: Aysegul Oruc, et al.
Published: (2024-12-01)

Coloring hot-dip galvanization of steel samples in industrial zinc-manganese baths
by: Godzsák M., et al.
Published: (2017-01-01)

Incidence and pathological features of IgA nephropathy before and during the COVID-19 pandemic
by: Wen Liu, et al.
Published: (2025-02-01)

Actinidia deliciosa as a complemental therapy against nephropathy and oxidative stress in diabetic rats
by: Ali Y. Naoom, et al.
Published: (2023-11-01)